IDI [IDI] 8-K: (Original Filing)

[CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements Form S-8 (Nos. 333-177025, 333-188739, 333-194952, 333-206043) and Form S-3 (Nos. 333-206402 and 333-205614) of IDI, Inc. (the “Company”) of our report dated April 27, 2015, on our audit of the consolidated balance sheet of Fluent, Inc. and subsidiaries as of] [Consent of Independent Auditors We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statements (Form S-3 No. 333-205614 and Form S-3 No. 333-206402) of IDI, Inc., (2) Registration Statement (Form S-8 No. 333-177025) pertaining to the SearchMedia Holdings Limited Amended and Restated 2008 Share Incentive Plan, (3) Registration Statements (Form S-8 No. 333-188739 and Form] [IDI Fluent IDI to Acquire Fluent Applying Next-Generation Data Analytics to Help Marketers Acquire their Best Customers at Scale © 2015 IDI, Inc. All rights reserved. This presentation is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments] [FLUENT, INC. AND SUBSIDIARIES Contents Page Consolidated Financial Statements Independent auditors’ report 1 Consolidated balance sheet as of December 31, 2014 2 Consolidated statement of income and comprehensive income for the year ended December 31, 2014 3 Consolidated statement of changes in stockholders’ equity for the year ended December 31, 2014 4 Consolidated statement of cash flows for the year] [ONSOLIDATED INANCIAL TATEMENTS C Fluent, Inc. and Subsidiaries Year Ended December 31, 2013 Fluent, Inc. and Subsidiaries Consolidated Financial Statements Year Ended December 31, 2013 Contents 1 Consolidated Financial Statements Consolidated Balance Sheet as of December 31, 2013 2 Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2013 and 2012 3 Consolidated Statements of Changes] [FLUENT, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NINE MONTHS ENDED SEPTEMBER 30, 2015 (UNAUDITED) FLUENT, INC. AND SUBSIDIARIES Contents Page Condensed Consolidated Financial Statements Condensed consolidated balance sheet as of September 30, 2015 (unaudited) 1 Condensed consolidated statement of income and comprehensive income for the nine months ended September 30, 2015 (unaudited) 2 Condensed consolidated statement of cash flows] [UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS Also, on November 16, 2015, the Company entered into a Stock Purchase Agreement for the sale of 119,940 shares of Series B Preferred to Frost Gamma in exchange for approximately $40.0 million. The following Unaudited Pro Forma Condensed Combined Financial Statements are based on the historical financial statements of IDI and Fluent after] [Item 7.01 Regulation FD Information Item 8.01. The Company is providing, through the filing of this Current Report on Form 8-K, certain financial information regarding Fluent and certain pro forma financial information regarding the Company and Fluent. The Company’s proposed acquisition of Fluent has not been consummated and remains subject to certain customary closing conditions.]

By | 2016-03-13T14:43:22+00:00 December 2nd, 2015|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

IDI [IDI] 8-K: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We

[CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements Form S-8 (Nos. 333-177025, 333-188739, 333-194952, 333-206043) and Form S-3 (Nos. 333-206402 and 333-205614) of IDI, Inc. (the “Company”) of our report dated April 27, 2015, on our audit of the consolidated balance sheet of Fluent, Inc. and subsidiaries as of] [Consent of Independent Auditors We consent to the incorporation by reference in the following Registration Statements: (1) Registration Statements (Form S-3 No. 333-205614 and Form S-3 No. 333-206402) of IDI, Inc., (2) Registration Statement (Form S-8 No. 333-177025) pertaining to the SearchMedia Holdings Limited Amended and Restated 2008 Share Incentive Plan, (3) Registration Statements (Form S-8 No. 333-188739 and Form] [IDI Fluent IDI to Acquire Fluent Applying Next-Generation Data Analytics to Help Marketers Acquire their Best Customers at Scale © 2015 IDI, Inc. All rights reserved. This presentation is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments] [FLUENT, INC. AND SUBSIDIARIES Contents Page Consolidated Financial Statements Independent auditors’ report 1 Consolidated balance sheet as of December 31, 2014 2 Consolidated statement of income and comprehensive income for the year ended December 31, 2014 3 Consolidated statement of changes in stockholders’ equity for the year ended December 31, 2014 4 Consolidated statement of cash flows for the year] [ONSOLIDATED INANCIAL TATEMENTS C Fluent, Inc. and Subsidiaries Year Ended December 31, 2013 Fluent, Inc. and Subsidiaries Consolidated Financial Statements Year Ended December 31, 2013 Contents 1 Consolidated Financial Statements Consolidated Balance Sheet as of December 31, 2013 2 Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2013 and 2012 3 Consolidated Statements of Changes] [FLUENT, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS NINE MONTHS ENDED SEPTEMBER 30, 2015 (UNAUDITED) FLUENT, INC. AND SUBSIDIARIES Contents Page Condensed Consolidated Financial Statements Condensed consolidated balance sheet as of September 30, 2015 (unaudited) 1 Condensed consolidated statement of income and comprehensive income for the nine months ended September 30, 2015 (unaudited) 2 Condensed consolidated statement of cash flows] [UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS Also, on November 16, 2015, the Company entered into a Stock Purchase Agreement for the sale of 119,940 shares of Series B Preferred to Frost Gamma in exchange for approximately $40.0 million. The following Unaudited Pro Forma Condensed Combined Financial Statements are based on the historical financial statements of IDI and Fluent after] [Item 7.01 Regulation FD Information Item 8.01. The Company is providing, through the filing of this Current Report on Form 8-K, certain financial information regarding Fluent and certain pro forma financial information regarding the Company and Fluent. The Company’s proposed acquisition of Fluent has not been consummated and remains subject to certain customary closing conditions.]

By | 2016-03-13T14:44:50+00:00 December 2nd, 2015|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

DHRM [Dehaier Medical Systems] 6-K/A: (Original Filing)

[Stock Code: 002280 Announcement Number: 2015-145 HangZhou Liaison Interactive Information Technology Co., Ltd Indicative Announcement on the Proposal of Purchasing The company and all the members of the Board of Directors ensurne that the announcement is true, accurate and complete, without any false information, misleading statement or material omission. Special note The non-binding offer to purchase the newly issued common] []

DHRM [Dehaier Medical Systems] 6-K/A: Stock Code: 002280 Announcement Number: 2015-145 HangZhou Liaison

[Stock Code: 002280 Announcement Number: 2015-145 HangZhou Liaison Interactive Information Technology Co., Ltd Indicative Announcement on the Proposal of Purchasing The company and all the members of the Board of Directors ensurne that the announcement is true, accurate and complete, without any false information, misleading statement or material omission. Special note The non-binding offer to purchase the newly issued common] []

CXDC [China XD Plastics Co] DEFR14A: CHINA XD PLASTICS COMPANY LIMITED No. 9 Dalian

[CHINA XD PLASTICS COMPANY LIMITED No. 9 Dalian North Road, Haping Road Centralized Industrial Park, Harbin Development Zone, Heilongjiang Province, PRC 150060 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS to be held on December 3, 2015 TO THE STOCKHOLDERS OF CHINA XD PLASTICS COMPANY LIMITED: The Annual Meeting of the Stockholders of China XD Plastics Company Limited, a Nevada corporation (the]

By | 2016-03-17T16:56:23+00:00 December 2nd, 2015|Categories: Chinese Stocks, CXDC, Webplus ver|Tags: , , , , , |0 Comments

GOMO [Sungy Mobile] SC 13D/A: JOINT FILING AGREEMENT Dated: December 2, 2015 IDG-ACCEL

[JOINT FILING AGREEMENT Dated: December 2, 2015 IDG-ACCEL CHINA GROWTH FUND L.P. IDG-ACCEL CHINA GROWTH FUND-A L.P. IDG-ACCEL CHINA INVESTORS L.P. IDG-ACCEL CHINA GROWTH FUND ASSOCIATES L.P. IDG-ACCEL CHINA GROWTH FUND GP ASSOCIATES LTD.] [SCHEDULE 13D (Amendment No. 2)* Sungy Mobile Limited (Name of Issuer) Class A Ordinary Shares, Par Value $0.0001 per Share (“Class A Ordinary Shares”) (Title of Class of Securities) (1) 86737M100 (CUSIP Number) Quan Zhou IDG Capital Management (HK) Limited Unit 5505, The Centre 99 Queen’s Road Central, Hong Kong + (852) 2529-1016 (Name, Address and Telephone Number of Person]

By | 2016-03-18T16:41:14+00:00 December 2nd, 2015|Categories: Chinese Stocks, GOMO, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the “Company”), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on November 25, 2015 from the NYSE MKT LLC (the “Exchange”) indicating that the Company is below certain] []

By | 2016-03-19T13:59:25+00:00 December 2nd, 2015|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: TPI Received Notice of Non-Compliance with NYSE MKT

[TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Tianyin Pharmaceutical Inc. (NYSE Amex: TPI) (the “Company”), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), received notice on November 25, 2015 from the NYSE MKT LLC (the “Exchange”) indicating that the Company is below certain] []

By | 2016-03-19T14:00:33+00:00 December 2nd, 2015|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar